The Hair Loss Encyclopedia

Search

for
Search:

GlossaryOmalizumab

medication that targets and blocks IgE to treat allergies

Omalizumab is a medication used to treat certain allergic conditions, such as chronic hives and severe asthma, by targeting and blocking immunoglobulin E (IgE), a protein involved in allergic reactions. It is a monoclonal antibody administered via injection and helps reduce the frequency and severity of allergic symptoms by preventing IgE from binding to its receptors on immune cells.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 56 results

research Transient Hair Loss in Patients With Chronic Spontaneous Urticaria Treated With Omalizumab

12 citations , November 2017 in “European Annals of Allergy and Clinical Immunology”

Omalizumab can cause temporary hair loss but still works well for chronic urticaria.

research Alopecia Areata After Omalizumab Treatment for Chronic Spontaneous Urticaria

11 citations , January 2019 in “Acta Dermato Venereologica”

Omalizumab may cause hair loss.

research Case Report: Omalizumab-Associated Hair Loss: A Case of Eyebrow Alopecia Areata, Literature Review and FAERS Database Analysis

June 2025 in “Frontiers in Medicine”

Omalizumab may cause temporary hair loss, especially in women aged 18-60.

research Learning From Success and Failure: Biologics for Non-Approved Skin Diseases

20 citations , August 2019 in “Frontiers in immunology”

Biologics show promise in treating various stubborn skin diseases, but more research and better reimbursement criteria are needed.

The Most Common Pediatric And Adult Dermatology Patient Complaints In A Month Of The COVID-19 Pandemic In Turkey

research The Most Common Pediatric And Adult Dermatology Patient Complaints In A Month Of The COVID-19 Pandemic In Turkey

7 citations , July 2020 in “Dermatologic Therapy”

During the COVID-19 pandemic in Turkey, the most common skin problem for both kids and adults was acne.

View more "omalizumab" in research →

Community Join

0 / 0 results

— no results